Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Bulova Technologies Group, Inc. | 2,000,000 | reported | 13 Jul 2014 | tx 1+2,000,000 |
| Propel Media, Inc. | 867,817 | reported | 05 May 2017 | tx 2+3,867,817 |
| DYNAMIC LEISURE CORP | 440,000 | reported | 06 Mar 2008 | tx 2+440,000 |
| VivoSim Labs, INC. | 52,000 | reported | 05 Sept 2019 | tx 3+128,500 |
| INTERCEPT PHARMACEUTICALS INC | 9,031 | reported | 01 May 2019 | tx 333+368,219−431,022 |
| Galecto, Inc. | 720 | reported | 18 Jun 2025 | tx 4+54,720 |
| GLOBAL BRASS & COPPER HOLDINGS, INC. | 0 | reported | 03 Feb 2014 | tx 4−21,110,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Jun 2025 | GRANT_AWARD | Galecto, Inc. | 720 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 14 Jun 2023 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 14 Jun 2022 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 05 Sept 2019 | GRANT_AWARD | VivoSim Labs, INC. | 52,000 | 0.00 USD | deriv |
| 01 May 2019 | SALE | INTERCEPT PHARMACEUTICALS INC | 2,000 | 86.28 USD | |
| 01 May 2019 | EXERCISE | INTERCEPT PHARMACEUTICALS INC | 2,000 | 31.90 USD | |
| 01 May 2019 | EXERCISE | INTERCEPT PHARMACEUTICALS INC | 2,000 | 0.00 USD | deriv |
| 15 Apr 2019 | SALE | INTERCEPT PHARMACEUTICALS INC | 2,000 | 95.00 USD | |
| 15 Apr 2019 | EXERCISE | INTERCEPT PHARMACEUTICALS INC | 2,000 | 31.90 USD | |
| 15 Apr 2019 | EXERCISE | INTERCEPT PHARMACEUTICALS INC | 2,000 | 0.00 USD | deriv |
| 03 Apr 2019 | SALE | INTERCEPT PHARMACEUTICALS INC | 562 | 115.01 USD | |
| 01 Apr 2019 | TAX_WITHHOLDING | INTERCEPT PHARMACEUTICALS INC | 482 | 111.50 USD | |
| 01 Mar 2019 | SALE | INTERCEPT PHARMACEUTICALS INC | 2,000 | 103.16 USD | |
| 01 Mar 2019 | EXERCISE | INTERCEPT PHARMACEUTICALS INC | 2,000 | 31.90 USD | |
| 01 Mar 2019 | EXERCISE | INTERCEPT PHARMACEUTICALS INC | 2,000 | 0.00 USD | deriv |
| 15 Feb 2019 | SALE | INTERCEPT PHARMACEUTICALS INC | 2,000 | 111.51 USD | |
| 15 Feb 2019 | EXERCISE | INTERCEPT PHARMACEUTICALS INC | 2,000 | 31.90 USD | |
| 15 Feb 2019 | EXERCISE | INTERCEPT PHARMACEUTICALS INC | 2,000 | 0.00 USD | deriv |
| 16 Jan 2019 | GRANT_AWARD | INTERCEPT PHARMACEUTICALS INC | 3,300 | 0.00 USD | |
| 16 Jan 2019 | GRANT_AWARD | INTERCEPT PHARMACEUTICALS INC | 5,300 | 0.00 USD | deriv |
| 04 Jan 2019 | SALE | INTERCEPT PHARMACEUTICALS INC | 474 | 97.48 USD | |
| 01 Jan 2019 | TAX_WITHHOLDING | INTERCEPT PHARMACEUTICALS INC | 736 | 100.79 USD | |
| 02 Jan 2019 | SALE | INTERCEPT PHARMACEUTICALS INC | 2,000 | 98.28 USD | |
| 02 Jan 2019 | EXERCISE | INTERCEPT PHARMACEUTICALS INC | 2,000 | 31.90 USD |
1 purchase reported after at least 12 months of silence — most recent on 05 May 2017.